Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma.

MRI PET glioblastoma hypoxia imaging radiation therapy

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2019
Historique:
received: 31 01 2019
accepted: 13 05 2019
entrez: 29 6 2019
pubmed: 30 6 2019
medline: 30 6 2019
Statut: epublish

Résumé

Severe hypoxia [oxygen partial pressure (pO

Identifiants

pubmed: 31249831
doi: 10.3389/fmed.2019.00117
pmc: PMC6582242
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

117

Références

Nature. 1976 Dec 9;264(5586):542-5
pubmed: 1004590
Radiother Oncol. 1999 Nov;53(2):127-31
pubmed: 10665789
Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):551-60
pubmed: 10837935
Radiat Res. 2000 Nov;154(5):485-96
pubmed: 11025645
Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1171-82
pubmed: 11240261
Nat Rev Cancer. 2002 Jan;2(1):38-47
pubmed: 11902584
Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):921-7
pubmed: 12377346
Nature. 1976 Mar 25;260(5549):316-8
pubmed: 1256569
Phys Med Biol. 2003 Jan 21;48(2):N31-5
pubmed: 12587912
Br J Radiol. 1953 Dec;26(312):638-48
pubmed: 13106296
Nature. 1956 Nov 3;178(4540):978-9
pubmed: 13378491
Radiat Res. 1958 Oct;9(4):422-37
pubmed: 13591515
Crit Rev Oncol Hematol. 2004 Aug;51(2):81-90
pubmed: 15276173
Lancet Oncol. 2005 Feb;6(2):112-7
pubmed: 15683820
J Nucl Med. 2005 Feb;46(2):253-60
pubmed: 15695784
Nature. 2006 May 25;441(7092):437-43
pubmed: 16724055
Phys Med Biol. 2006 Oct 7;51(19):4903-21
pubmed: 16985278
Phys Med Biol. 2007 Jan 21;52(2):499-513
pubmed: 17202629
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):515-21
pubmed: 17398015
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):390-6
pubmed: 17459607
Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1496-504
pubmed: 17674980
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):2-13
pubmed: 17869020
Semin Nucl Med. 2007 Nov;37(6):451-61
pubmed: 17920352
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):235-42
pubmed: 18086391
Nat Rev Cancer. 2008 Mar;8(3):180-92
pubmed: 18273037
Eur J Cancer. 1991;27(7):887-93
pubmed: 1834122
Clin Cancer Res. 2008 May 1;14(9):2623-30
pubmed: 18451225
Nat Rev Cancer. 2008 Jun;8(6):425-37
pubmed: 18500244
Phys Med Biol. 2008 Aug 7;53(15):4153-67
pubmed: 18635895
Radiat Res. 1991 Sep;127(3):297-307
pubmed: 1886986
Cancer Res. 2009 Jan 15;69(2):383-92
pubmed: 19147546
Radiat Res. 2009 Mar;171(3):379-86
pubmed: 19267566
J Nucl Med. 2009 Jul;50(7):1020-7
pubmed: 19525447
Artif Cells Blood Substit Immobil Biotechnol. 2009;37(4):156-62
pubmed: 19548131
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):98-105
pubmed: 19695794
Med Phys. 2009 Aug;36(8):3568-74
pubmed: 19746791
Radiat Res. 2009 Dec;172(6):653-65
pubmed: 19929412
Mutat Res. 2010 Apr-Jun;704(1-3):160-6
pubmed: 20034592
Transl Oncol. 2010 Jun 01;3(3):160-9
pubmed: 20563257
BMC Cancer. 2010 Sep 06;10:478
pubmed: 20819220
Radiother Oncol. 2010 Nov;97(2):176-82
pubmed: 20855118
Semin Radiat Oncol. 2011 Apr;21(2):101-10
pubmed: 21356478
Drug Resist Updat. 2011 Jun;14(3):191-201
pubmed: 21466972
Phys Med Biol. 2011 Jun 7;56(11):3251-68
pubmed: 21540489
Acta Oncol. 2012 Feb;51(2):222-30
pubmed: 21871003
Radiother Oncol. 2011 Dec;101(3):369-75
pubmed: 21872957
Radiat Oncol. 2012 Jan 27;7:9
pubmed: 22284807
Comput Math Methods Med. 2012;2012:410602
pubmed: 22400049
Radiother Oncol. 2012 Oct;105(1):29-35
pubmed: 22677038
Radiother Oncol. 2012 Oct;105(1):21-8
pubmed: 23022173
Acta Oncol. 2013 Nov;52(8):1723-9
pubmed: 23317145
J Nucl Med. 2013 Feb;54(2):201-7
pubmed: 23321456
Biol Chem. 2013 Apr;394(4):529-39
pubmed: 23399636
Cancer Res. 2013 Sep 15;73(18):5618-24
pubmed: 23764543
J Neurooncol. 2013 Nov;115(2):197-207
pubmed: 23918147
Neuroimage. 2014 Apr 1;89:262-70
pubmed: 24321559
Radiat Oncol. 2014 Mar 28;9(1):88
pubmed: 24679134
Int J Radiat Biol. 2014 Dec;90(12):1125-32
pubmed: 24882391
Head Neck. 2015 Oct;37(10):1524-31
pubmed: 24890445
Surg Neurol Int. 2014 May 08;5:64
pubmed: 24991467
J Cereb Blood Flow Metab. 2014 Sep;34(9):1550-7
pubmed: 25005878
Clin Cancer Res. 2014 Nov 1;20(21):5403-11
pubmed: 25208881
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):877-85
pubmed: 25257812
Clin Cancer Res. 2014 Dec 15;20(24):6389-97
pubmed: 25316821
Pract Radiat Oncol. 2015 Jan-Feb;5(1):e9-16
pubmed: 25413424
Br J Cancer. 2015 Jan 20;112(2):238-50
pubmed: 25514380
Acta Oncol. 2015;54(9):1370-7
pubmed: 26203928
Acta Oncol. 2015;54(9):1607-13
pubmed: 26213311
Front Med (Lausanne). 2015 Aug 19;2:57
pubmed: 26347870
Front Med (Lausanne). 2015 Aug 24;2:58
pubmed: 26380261
Sci Rep. 2015 Nov 24;5:17016
pubmed: 26596243
Cancer Res. 2016 Feb 15;76(4):787-95
pubmed: 26659574
Oncoimmunology. 2015 Jun 5;5(1):e1056442
pubmed: 26942063
J Radiat Res. 2016 Aug;57 Suppl 1:i90-i98
pubmed: 26983987
Clin Cancer Res. 2016 Oct 15;22(20):5079-5086
pubmed: 27185374
J Cereb Blood Flow Metab. 2017 Jun;37(6):2270-2282
pubmed: 27496553
J Cereb Blood Flow Metab. 2017 Jul;37(7):2584-2597
pubmed: 27702880
Oncotarget. 2017 May 9;8(19):31864-31875
pubmed: 28418866
Oncotarget. 2017 Jun 13;8(24):39774-39781
pubmed: 28427153
Acta Oncol. 2017 Jun;56(6):819-825
pubmed: 28464740
Br J Radiol. 2017 Aug;90(1076):20160939
pubmed: 28540739
Radiother Oncol. 2017 Sep;124(3):365-369
pubmed: 28545957
Radiother Oncol. 2017 Sep;124(3):533-540
pubmed: 28843726
Sci Rep. 2017 Aug 31;7(1):10210
pubmed: 28860608
Sci Rep. 2017 Oct 31;7(1):14403
pubmed: 29089533
Br J Radiol. 2018 Feb;91(1082):20170628
pubmed: 29172684
Sci Rep. 2018 Jan 18;8(1):1141
pubmed: 29348437
Mol Imaging Biol. 2019 Feb;21(1):122-129
pubmed: 29845425
Clin Cancer Res. 2019 Jan 1;25(1):35-42
pubmed: 29875213
Appl Radiat Isot. 2018 Sep;139:316-324
pubmed: 29890472
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1165-1182
pubmed: 29907486
Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):619-626
pubmed: 30017793
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2201-2217
pubmed: 30128659
Ann Nucl Med. 2018 Nov;32(9):579-582
pubmed: 30242670
Int J Nanomedicine. 2018 Oct 04;13:6049-6058
pubmed: 30323592
Radiat Oncol. 2018 Oct 23;13(1):208
pubmed: 30352608
Sci Rep. 2018 Nov 2;8(1):16257
pubmed: 30390002
Cancer Treat Rev. 2019 Jan;72:56-64
pubmed: 30530009
Radiat Prot Dosimetry. 2019 May 1;183(1-2):247-250
pubmed: 30535354
Radiother Oncol. 1985 Feb;3(2):97-115
pubmed: 3157206
Cancer Res. 1987 Jan 15;47(2):597-601
pubmed: 3791244
Radiology. 1972 Oct;105(1):135-42
pubmed: 4506641
Int J Radiat Biol Relat Stud Phys Chem Med. 1974 Sep;26(3):203-18
pubmed: 4609938
Cancer Chemother Rep. 1970 Jun;54(3):143-74
pubmed: 5527016
Radiat Res. 1995 May;142(2):163-8
pubmed: 7724730
Int J Radiat Oncol Biol Phys. 1994 Jun 15;29(3):427-31
pubmed: 8005794
Int J Radiat Biol. 1996 Mar;69(3):351-8
pubmed: 8613685
Radiat Res. 1997 May;147(5):541-50
pubmed: 9146699

Auteurs

Michael Gérard (M)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.
Department of Radiation Oncology, Centre Lutte Contre le Cancer François Baclesse, Caen, France.

Aurélien Corroyer-Dulmont (A)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.

Paul Lesueur (P)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.
Department of Radiation Oncology, Centre Lutte Contre le Cancer François Baclesse, Caen, France.

Solène Collet (S)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.
Department of Radiophysics, Centre Lutte Contre le Cancer François Baclesse, Caen, France.

Michel Chérel (M)

Team 13-Nuclear Oncology, INSERM U1232 Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA), Nantes, France.

Mickael Bourgeois (M)

Team 13-Nuclear Oncology, INSERM U1232 Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA), Nantes, France.

Dinu Stefan (D)

Department of Radiation Oncology, Centre Lutte Contre le Cancer François Baclesse, Caen, France.

Elaine Johanna Limkin (EJ)

Department of Radiotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France.

Cécile Perrio (C)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/LDM-TEP Group, GIP Cyceron, Caen, France.

Jean-Sébastien Guillamo (JS)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.
Department of Neurology, Centre Hospitalier Universitaire de Nîmes, Nîmes, France.

Bernard Dubray (B)

Département de Radiothérapie et de Physique Médicale, Laboratoire QuantIF-LITIS [EA 4108], Centre de Lutte Contre le Cancer Henri Becquerel, Université de Normandie, Rouen, France.

Myriam Bernaudin (M)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.

Juliette Thariat (J)

Department of Radiation Oncology, Centre Lutte Contre le Cancer François Baclesse, Caen, France.

Samuel Valable (S)

Normandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.

Classifications MeSH